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Abstract
Background—The presence of depression after an acute coronary syndrome (ACS) is associated
with worse prognosis and lower adherence to risk reducing behaviors. We reported earlier that an
enhanced depression care intervention reduces depression symptoms and major adverse cardiac
events. This study evaluates the impact of the depression intervention on health behavior and
blood pressure control.
Methods—Between 2005 and 2008, 157 patients who remained persistently depressed 3-months
after ACS were randomized to a 6 month depression intervention (initial patient preference for
problem-solving therapy and/or pharmacotherapy, followed by stepped-care; 80 patients) or to
usual care (77 patients). At randomization, and then 2, 4, and 6 months later, patients were asked
if they 1) missed taking their aspirin; 2) followed a heart healthy diet; 3) exercised regularly; and
4) used tobacco products. Blood pressure was measured prior to randomization and 6 months later.
Results—At the end of the intervention, there was no significant improvement in the percentage
of intervention compared to control group patients that adhered to aspirin (+3% versus −1%,
p=0.23); followed a healthy diet (+10% versus +8%, p=0.39); exercised regularly (+5% versus
+4%, p=0.65); abstained from tobacco (−3% versus −1%, p=0.77); or had controlled blood
pressure (+6% versus +16%, p=0.26).
Conclusion—Despite improving depression, enhanced depression care after an ACS did not
improve health behavior or blood pressure control compared to usual care. Research is needed to
test whether adding an adherence intervention to enhanced depression care can improve adherence
and cardiovascular prognosis in depressed post-ACS patients.
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The presence of depression after an acute coronary syndrome(myocardial infarction,
unstable angina; ACS) is an independent risk factor for recurrent cardiovascular events and
mortality. Depression after an ACS is also associated with lower adherence to
cardiovascular risk reducing behaviors such as physical activity, smoking cessation, and
taking cardiovascular medications.3–6 Lower adherence to these healthy behaviors may
explain a portion of the association between depression and worse prognosis in patients with
either stable coronary heart disease (CHD)or after ACS.7–9 Despite the strong association
between depression and non-adherence in observation studies, it remains unknown whether
treatment of depression improves patients’ adherence to healthy behaviors after ACS.
In the Coronary Psychosocial Evaluation Studies (COPES)randomized controlled trial, we
previously found that an enhanced depression care intervention comprised of patient
preference for problem-solving therapy (PST), antidepressant medications, or both, followed
by stepped care according to treatment response, was effective at reducing depressive
symptoms after an ACS.10 At the end of the trial, patients in the intervention group were
more likely to be taking antidepressant medications and participating in psychotherapy.10
Moreover, they had a 31% reduction in their depressive symptoms, while participants in the
usual care group only had a 9% reduction in depressive symptoms. With a standardized
effect size of 0.59, this intervention compares favorably with other evidence-based
interventions for depression in patients with cardiovascular disease.11 Patients randomized
to this intervention also had a lower occurrence of major adverse coronary events(MACE)
during the intervention period.10
Because we had found a reduced MACE rate in the intervention group, we tested in this
secondary analysis the impact of enhanced depression care on self-reported risk reducing
behaviors including regularly taking prescribed medications, following a heart healthy diet,
exercising regularly, and abstaining from tobacco products. We also assessed the impact of
the intervention on objectively measured blood pressure control, a cardiac risk factor that is
partially mediated by adherence to exercise, diet, and medications. We hypothesized that as
compared to usual care, enhanced depression care would result in better adherence to risk
reducing behaviors after an ACS and better blood pressure control, and that this
improvement might explain in part the improved MACE rate in the COPES depression trial.
Methods
The COPES trial design is described elsewhere.12 Briefly, 157 hospitalized ACS patients
who were persistently depressed (Beck Depression Inventory (BDI)13 score ≥10 within 1-
week of hospitalization and again 3 months later) were recruited from 5 US hospitals(Mount
Sinai Hospital and New York Presbyterian Hospital, New York, New York; and New Haven
Hospital, Hospital of St Raphael, and Veterans Affairs Connecticut Healthcare System-West
Haven, New Haven, Connecticut) between 2005 and 2008 and randomized to receive six
months of enhanced depression care or to usual care. Exclusion criteria were alcohol or drug
dependency, dementia, psychosis, bipolar disorder, terminal illness, unavailability for
follow-up, BDI score of ≥ 45, or suicidality. The institutional review boards at all
institutions approved the protocol, and all participants provided written informed consent.
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solely responsible for the design and conduct of this study, all study analyses and drafting
and editing of the paper.
Enhanced depression care consisted of patient preference for either brief problem solving
therapy (PST) and/or pharmacotherapy, followed by stepped-care in which symptom
severity was reviewed every 6 to 8 weeks and treatment was augmented, maintained, or
switched according to predetermined decision rules. PST therapists did not assess or advise
patients on adherence issues unless the patient chose this issue as a focus for their PST
sessions. The risk of contamination between groups was minimized as enhanced depression
care visits took place in research settings rather than at clinical sites. Usual care consisted of
notifying treating physician(s) about their patients’ depressive status; patients can then
receive whichever care for depressive symptoms that their clinician(s) feels is warranted.
Measures
Adherence was assessed via patient interview by assessors who were blinded to patients’
group assignment. Specifically, at the time of ACS, patients were asked to report “Yes/No”
whether, in the 3 months prior, 1) they were exercising regularly; 2) they were following a
low fat, low cholesterol diet; and 3) whether in the prior week they had used tobacco
products. A trandomization (3 months after the index ACS) and 2, 4, and 6 months later,
adherence to these behaviors since the prior study visit was assessed using the same
questions. In addition, patients were asked if they had missed taking their aspirin on any day
since that prior visit. Similar questions were used to assess adherence after ACS assessments
2 and 4 months after randomization were made over the telephone; all other assessments
were done in-person.
Blood pressure was recorded at 3 in-person study visits (ACS hospitalization, 3 months and
9 months later)as the average of two measurements from the same non-dominant arm using
an appropriately sized cuff and a mercury sphygmomanometer. Measurements were taken at
least two minutes apart and after the patient had been seated for at least 5 minutes. Blood
pressure was measured at the pre-randomization visit (3 months after hospitalization) and 6
months later. Blood pressure control was defined as having a systolic blood pressure less
than 140 mmHg and a diastolic blood pressure less than 90 mmHg.
Other variables including patient demographics, alcohol use, and cardiac rehabilitation
participation were assessed through patient interview. At-risk alcohol use was defined as
more than two drinks per day for men and more than one drink per day for women. Medical
characteristics including left ventricular ejection fraction and cardiac disease prognosis as
measured by the Global Registry of Acute Coronary Events14 score were assessed through
chart abstraction.
Statistical Analysis
Of the 80 intervention patients and the 77 usual care patients, 81% and 92% had complete
data on self-reported adherence and 79% and 85% had complete data on blood pressure,
respectively. Chi-square tests revealed that patients who reported being non-adherent at the
time of the index hospitalization were not more likely to have subsequent missing data.
Missing data were handled using multiple imputation (five datasets); multiple imputation
was performed separately for each adherence behavior. Variables that were associated with
adherence to health behaviors in prior studies (age, gender, race, ethnicity, depression
severity) were used as predictors in the multiple imputation procedure.3
In an exploratory analysis, we used McNemar’s test to assess whether adherence to risk
reducing behaviors significantly improved between the index ACS hospitalization and the
pre-randomization visit 3 months later, irrespective of group assignment. For our main
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analysis, we used logistic regression, pooling the results across the five multiply imputed
datasets, to assess whether the intervention was associated with increased odds of adherence
to aspirin, diet, exercise, and abstinence from smoking, as well as blood pressure control
during the intervention period. In each analysis, adherence at the beginning of the
intervention period was treated as a covariate. For blood pressure, we also used t-tests to
compare the mean blood pressure at 9 months and the change in blood pressure between 3
months and 9 months in enhanced versus usual care group patients. We also estimated the
sample sizes that would have been needed to detect significant effects of the COPES
intervention on adherence given the odds ratios found in these analyses and assuming 80%
power. All analyses were performed using SPSS statistical software (version 18, SPSS Inc.,
Chicago, IL).
Results
As has been previously reported, the mean age of patients in the trial was 60 years,54% were
women, 43% were Hispanic, and 17% were Black.10 Enhanced and usual care patients were
similar on demographic and medical characteristics at the time of the index ACS
hospitalization(Table 1).
At the time of the index hospitalization, there were no significant differences in the
percentage of patients in each group who reported exercising regularly, following a heart
healthy diet, never missing their medications, and abstaining from tobacco (Figure). Other
than for at-risk alcohol use, adherence to healthy behaviors was suboptimal 3 months after
the index ACS hospitalization (the time of randomization), and ranged from a low of 43% of
participants regularly exercising to a high of 83% of participants abstaining from tobacco
(Figure).No patients in either group reported at-risk alcohol use at 3 months and only 1
patient (in the control group) reported at-risk alcohol use at 9 months. The percentage of
patients participating in cardiac rehabilitation at 3 months was similar in both groups (22%
intervention versus 16% usual care; p=0.36).
Irrespective of randomization assignment, there was a significant (p<0.05) increase in the
percentage of patients who reported being adherent to following a healthy diet (45% to
66%)and to regular exercise (29% to 43%), 3 months after the index ACS hospitalization
versus at the time of the index ACS. In contrast, there was no significant change in the
percentages of the intervention and usual care groups that abstained from smoking (81% to
83%) or had controlled blood pressure (78% to 69%) over this time period, respectively.
Similarly, there were no significant differences in blood pressure at 9 months or in the
change in systolic blood pressure between 9 months and 3 months.
During the intervention period, there were small relative improvements in adherence to
aspirin, healthy diet, and regular exercise, but these improvements were not statistically
significant (Table 2; Figure). Furthermore, there were no significant differences in mean
systolic blood pressure at 9 months, nor in the change in systolic blood pressure between 3
months and 9 months between both groups (data not shown). We estimated that we would
have needed to enroll from 872 patients in the case of aspirin adherence to 6039 patients in
the case of adherence to regular exercise to have sufficient sample size to find statistically
significant differences in these health behaviors with the odds ratios found in our study. The
effect of the intervention on use of tobacco products and blood pressure control were in the
direction of causing harm, but again, these differences were not statistically significant. The
results showing no difference were the same when analyzed using list wise deletion and
when performed with the assumption that missing data represented non-adherence (data not
shown).
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Despite resulting in improved depressive symptoms, increased receipt of psychotherapy and
antidepressants, and a lower MACE rate, the COPES enhanced depression care intervention
did not have a comparable beneficial effect on self-reported adherence to cardiovascular risk
reducing behaviors including taking aspirin every day, following a healthy diet, regularly
exercising, and abstaining from tobacco products. Similarly, the COPES intervention did not
improve the proportion of patients with controlled blood pressure. A number of biological
mechanisms such as platelet hyperreactivity and autonomic dysfunction have been proposed
to explain the association between depression and poor post-ACS prognosis. Hence, it is
possible that enhanced depression care may improve post-ACS outcomes by acting on
biological pathways not measured in this study. For example, patients with greater declines
in depressive symptoms as a result of enhanced depression care may have had less reactive
platelets and greater heart rate variability which, in turn, could have reduced the risk of
recurrent MI and sudden cardiac death, respectively.
Although our finding that enhanced depression care did not improve adherence was contrary
to the hypothesis generated by observational studies, our finding was consistent with the
results of a prior trials of enhanced depression care incardiac17 and diabetic patients18 with
comorbid depression. In both cases, despite improving depressive symptoms, enhanced
depression care did not improve self-reported adherence by the end of the trial. Our study
expands upon this literature by testing the effect of a more intensive depression intervention
targeted at patients with persistently elevated depressive symptoms after ACS. Furthermore,
our study assesses the effect of the intervention on smoking and blood pressure, key
cardiovascular risk factors. Thus, enhanced depression care, alone, may not be adequate for
improving adherence to health behaviors related to comorbid medical illness.
There are several additional potential interpretations of the current findings. First, it is
possible that treating depression may be necessary but not sufficient to improve health
behavior in patients with comorbid medical illness. For example, Trockel and colleagues
reported that enhanced depression care resulted in increased smoking cessation in post-MI
patients only for patients with adequate social support.19 Another possibility is that despite
the relatively strong effect size of the COPES intervention on depressive symptoms, this and
other effective depression interventions may not be potent enough to produce the increased
energy, motivation, and concentration that may be necessary to have a significant impact on
adherence behaviors.
Although the COPES intervention did not improve health behaviors, we observed significant
improvements in adherence to exercise and healthy diet three months after hospitalization
for an ACS (prior to the start of the intervention) in the sample as a whole. This
substantiates the potential for cardiovascular events to serve as the basis for a “teachable
moment” that can spur behavior change even among the persistently depressed patients who
were eligible for this study.20
There are several limitations to our conclusion that enhanced depression care does not result
in improved adherence. First, these were post-hoc analyses.21 Of greater concern, adherence
behaviors were measured using single-item, dichotomous, self-report questions and thus
were imprecise. In addition, self-report can inflate the true rate of adherence due to recall or
social desirability bias.22 Nevertheless, in a prior observational study, we found that changes
in responses to similar questions for diet, exercise, and smoking were associated with
changes in depression in the first 3 months after ACS.13 In addition, we were reassured that
the questions assessing diet and exercise were sensitive to change between hospitalization
and 3 months in the current study. Future studies should consider carefully measuring
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adherence using either validated scales or objective instruments such as electronic monitors
for medication adherence and actigraphs for exercise. In addition, it is possible that
enhanced depression care could have a delayed effect on adherence behaviors after the
conclusion of the trial as has been found in one prior trial of enhanced depression care in
cardiac patients,17 but we did not test for this in our study. Finally, this study may have been
underpowered for these secondary analyses, though even if the enhanced depression
intervention did improve adherence to some behaviors, these improvements were unlikely to
be clinically meaningful.
Implications
Rates of adherence to risk reducing behaviors were suboptimal for both enhanced depression
and usual care patients and thus represent appropriate targets for intervention. Future trials
of enhanced depression care that seek to improve cardiovascular outcomes along with
depression symptoms might consider multi-modal approaches that incorporate depression
treatment with adherence training.23 A collaborative care depression intervention in patients
with diabetes or stable coronary heart disease that targeted not only depression, but also
cardiovascular risk factor control via more aggressive medication intensification and
adherence counseling resulted in improvements in depression as well as diabetes,
cholesterol, and blood pressure control, but not in adherence to health behaviors. Hence,
future trials will need to consider alternative approaches to improving health behavior in
depressed cardiovascular patients. Determining whether to offer depression treatment prior
to intervening on adherence behaviors or whether to address depression and non-adherence
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Percentage of Patients in Intervention and Usual Care Groups Who Adhere to Risk
Reducing Behaviors after Acute Coronary Syndromes.* Top Left: Never Missing Aspirin;
Top Right: Following Heart Healthy Diet; Bottom Left: Exercising Regularly; Bottom
Right: Abstaining from Tobacco Products
*Randomization occurred at 3 months
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Table 1
Patient Characteristics at Prior to Randomization into the COPES Enhanced Depression Care Randomized
Controlled Trial*
Characteristic Intervention (n=80) Usual Care (n=77) P-Value
Age, mean in years (SD) 59.3 (10.6) 61.1 (10.6) 0.29
Female 43 (54) 41 (53) 0.95
Black 12 (15) 17 (22) 0.25
Hispanic 36 (45) 32 (42) 0.66
Type of acute coronary syndrome
 Myocardial infarction 21 (26) 17 (22) 0.69
 Unstable angina 58 (73) 60 (78)
GRACE score, mean (SD) 91 (24) 94 (23) 0.48
LVEF < 40% 7(11) 7 (11) 0.99
*
Unless otherwise indicated, data are expressed as number (percentage) of patients.
Abbreviations: SD, standard deviation; GRACE, Global Registry of Acute Coronary Events;LVEF, left ventricular ejection fraction
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